Show simple item record

dc.contributor.authorQuinn, AM
dc.contributor.authorGosney, J
dc.contributor.authorBishop, P
dc.contributor.authorBloor, R
dc.contributor.authorHarreld, C
dc.contributor.authorMcnulty, C
dc.contributor.authorBowden, R
dc.contributor.authorMoss, A
dc.contributor.authorForrest, S
dc.contributor.authorMontero, A
dc.contributor.authorChaturvedi, A
dc.contributor.authorJoseph, L
dc.contributor.authorPaiva-Correia, A
dc.contributor.authorDoran, H
dc.contributor.authorTaniere, P
dc.contributor.authorCrosbie, P
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorSummers, Yvonne J
dc.date.accessioned2019-02-08T15:20:02Z
dc.date.available2019-02-08T15:20:02Z
dc.date.issued2018en
dc.identifier.citationQuinn AM, Gosney J, Bishop P, Bloor R, Harreld C, Mcnulty C, et al. P2.09-06 Expression of PD-L1 on routine non-small cell lung carcinoma sections: comparative assessment of SP263 (Ventana) and 22C3 (DAKO pharmDx). J Thorac Oncol. 2018 Oct;13(10):S761-S763.en
dc.identifier.doi10.1016/j.jtho.2018.08.1303en
dc.identifier.urihttp://hdl.handle.net/10541/621480
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jtho.2018.08.1303en
dc.titleExpression of PD-L1 on routine non-small cell lung carcinoma sections: comparative assessment of SP263 (Ventana) and 22C3 (DAKO pharmDx)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentCellular Pathology, Wythenshawe Hospital, Manchester NHS Foundation Trust, Wythenshawe/GBen
dc.identifier.journalJournal of Thoracic Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record